Skip to main content


Ürünlerimiz - Proton Pharma Since the publication of the Code on Interactions with Healthcare Professionals and therefore the Compliance Program Guidance for Pharma Manufacturers in 2002, pharma manufacturers have clearly separated their marketing and medical information functions. Nonetheless, so as to enhance patient insights and outcomes, the wealth of interactions and data medical information teams collect can and will be used strategically to get important insights for the medical affairs team—as well because the entire organization—including commercial functions. Indeed, the medical information function should be a crucial partner in shaping the thinking around patient journeys, potential difficulties with application, or detailing additional indications for clinical trials, to call a couple of potential areas of contribution.